Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum NeutriSci International Inc V.NU.H

Alternate Symbol(s):  NRXCF

NeutriSci International Inc. (NeutriSci) is a Canada-based company, which specializes in the production, and formulation of nutraceutical products within the business-to-business (B2B) industry. The Company is focused on the market development for its nutraceutical products. Its products utilize patented form of Pterostilbene called pTeroPure. pTeroPure Pterostilbene is a form of all-trans... see more

TSXV:NU.H - Post Discussion

NeutriSci International Inc > $0.07-0.005 | -6.67%
View:
Post by BradlTheGerman on Sep 30, 2021 10:24am

$0.07-0.005 | -6.67%

By the dip Ed - good success !
Comment by Edcando on Sep 30, 2021 10:31am
Still an average up Bradthejiltedlover . Only picked up that small amount this morning to confirm the games I suspect.  Show us on the doll where the ceo touched you and ruined you for all other ceos.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities